## Abstract

The presented paper modeled and predicted stock returns using LSTM. The historical data of stock market were transformed into 30-days-long sequences with 10 learning features and 7-day earning rate labeling. The model was fitted by training on 1200000 sequences and tested using the other 350000 sequences. (Hegazy, O., Soliman, O.S. and Salam, M.A., 2014. A machine learning model for stock market prediction. arXiv preprint arXiv:1402.7351.)** We evaluate ICU Medical Inc. Common Stock prediction models with Statistical Inference (ML) and Spearman Correlation ^{1,2,3,4} and conclude that the ICUI stock is predictable in the short/long term. **

**According to price forecasts for (n+16 weeks) period: The dominant strategy among neural network is to Buy ICUI stock.**

## Key Points

- What are buy sell or hold recommendations?
- Can statistics predict the future?
- What is prediction model?

## ICUI Target Price Prediction Modeling Methodology

We consider ICU Medical Inc. Common Stock Decision Process with Statistical Inference (ML) where A is the set of discrete actions of ICUI stock holders, F is the set of discrete states, P : S × F × S → R is the transition probability distribution, R : S × F → R is the reaction function, and γ ∈ [0, 1] is a move factor for expectation.^{1,2,3,4}

F(Spearman Correlation)

^{5,6,7}= $\begin{array}{cccc}{p}_{\mathrm{a}1}& {p}_{\mathrm{a}2}& \dots & {p}_{1n}\\ & \vdots \\ {p}_{j1}& {p}_{j2}& \dots & {p}_{jn}\\ & \vdots \\ {p}_{k1}& {p}_{k2}& \dots & {p}_{kn}\\ & \vdots \\ {p}_{n1}& {p}_{n2}& \dots & {p}_{nn}\end{array}$ X R(Statistical Inference (ML)) X S(n):→ (n+16 weeks) $\sum _{i=1}^{n}\left({r}_{i}\right)$

n:Time series to forecast

p:Price signals of ICUI stock

j:Nash equilibria (Neural Network)

k:Dominated move

a:Best response for target price

For further technical information as per how our model work we invite you to visit the article below:

How do AC Investment Research machine learning (predictive) algorithms actually work?

## ICUI Stock Forecast (Buy or Sell) for (n+16 weeks)

**Sample Set:**Neural Network

**Stock/Index:**ICUI ICU Medical Inc. Common Stock

**Time series to forecast n: 05 Dec 2022**for (n+16 weeks)

**According to price forecasts for (n+16 weeks) period: The dominant strategy among neural network is to Buy ICUI stock.**

**X axis: *Likelihood%** (The higher the percentage value, the more likely the event will occur.)

**Y axis: *Potential Impact%** (The higher the percentage value, the more likely the price will deviate.)

**Z axis (Yellow to Green): *Technical Analysis%**

## Adjusted IFRS* Prediction Methods for ICU Medical Inc. Common Stock

- Accordingly the date of the modification shall be treated as the date of initial recognition of that financial asset when applying the impairment requirements to the modified financial asset. This typically means measuring the loss allowance at an amount equal to 12-month expected credit losses until the requirements for the recognition of lifetime expected credit losses in paragraph 5.5.3 are met. However, in some unusual circumstances following a modification that results in derecognition of the original financial asset, there may be evidence that the modified financial asset is credit-impaired at initial recognition, and thus, the financial asset should be recognised as an originated credit-impaired financial asset. This might occur, for example, in a situation in which there was a substantial modification of a distressed asset that resulted in the derecognition of the original financial asset. In such a case, it may be possible for the modification to result in a new financial asset which is credit-impaired at initial recognition.
- The methods used to determine whether credit risk has increased significantly on a financial instrument since initial recognition should consider the characteristics of the financial instrument (or group of financial instruments) and the default patterns in the past for comparable financial instruments. Despite the requirement in paragraph 5.5.9, for financial instruments for which default patterns are not concentrated at a specific point during the expected life of the financial instrument, changes in the risk of a default occurring over the next 12 months may be a reasonable approximation of the changes in the lifetime risk of a default occurring. In such cases, an entity may use changes in the risk of a default occurring over the next 12 months to determine whether credit risk has increased significantly since initial recognition, unless circumstances indicate that a lifetime assessment is necessary
- The definition of a derivative in this Standard includes contracts that are settled gross by delivery of the underlying item (eg a forward contract to purchase a fixed rate debt instrument). An entity may have a contract to buy or sell a non-financial item that can be settled net in cash or another financial instrument or by exchanging financial instruments (eg a contract to buy or sell a commodity at a fixed price at a future date). Such a contract is within the scope of this Standard unless it was entered into and continues to be held for the purpose of delivery of a non-financial item in accordance with the entity's expected purchase, sale or usage requirements. However, this Standard applies to such contracts for an entity's expected purchase, sale or usage requirements if the entity makes a designation in accordance with paragraph 2.5 (see paragraphs 2.4–2.7).
- When an entity discontinues measuring the financial instrument that gives rise to the credit risk, or a proportion of that financial instrument, at fair value through profit or loss, that financial instrument's fair value at the date of discontinuation becomes its new carrying amount. Subsequently, the same measurement that was used before designating the financial instrument at fair value through profit or loss shall be applied (including amortisation that results from the new carrying amount). For example, a financial asset that had originally been classified as measured at amortised cost would revert to that measurement and its effective interest rate would be recalculated based on its new gross carrying amount on the date of discontinuing measurement at fair value through profit or loss.

*International Financial Reporting Standards (IFRS) are a set of accounting rules for the financial statements of public companies that are intended to make them consistent, transparent, and easily comparable around the world.

## Conclusions

ICU Medical Inc. Common Stock assigned short-term B3 & long-term B3 forecasted stock rating.** We evaluate the prediction models Statistical Inference (ML) with Spearman Correlation ^{1,2,3,4} and conclude that the ICUI stock is predictable in the short/long term.**

**According to price forecasts for (n+16 weeks) period: The dominant strategy among neural network is to Buy ICUI stock.**

### Financial State Forecast for ICUI ICU Medical Inc. Common Stock Options & Futures

Rating | Short-Term | Long-Term Senior |
---|---|---|

Outlook* | B3 | B3 |

Operational Risk | 52 | 44 |

Market Risk | 59 | 83 |

Technical Analysis | 42 | 35 |

Fundamental Analysis | 54 | 30 |

Risk Unsystematic | 43 | 30 |

### Prediction Confidence Score

## References

- Mikolov T, Chen K, Corrado GS, Dean J. 2013a. Efficient estimation of word representations in vector space. arXiv:1301.3781 [cs.CL]
- Bai J. 2003. Inferential theory for factor models of large dimensions. Econometrica 71:135–71
- J. Filar, L. Kallenberg, and H. Lee. Variance-penalized Markov decision processes. Mathematics of Opera- tions Research, 14(1):147–161, 1989
- Bottomley, P. R. Fildes (1998), "The role of prices in models of innovation diffusion," Journal of Forecasting, 17, 539–555.
- Bertsimas D, King A, Mazumder R. 2016. Best subset selection via a modern optimization lens. Ann. Stat. 44:813–52
- Wager S, Athey S. 2017. Estimation and inference of heterogeneous treatment effects using random forests. J. Am. Stat. Assoc. 113:1228–42
- Thompson WR. 1933. On the likelihood that one unknown probability exceeds another in view of the evidence of two samples. Biometrika 25:285–94

## Frequently Asked Questions

Q: What is the prediction methodology for ICUI stock?A: ICUI stock prediction methodology: We evaluate the prediction models Statistical Inference (ML) and Spearman Correlation

Q: Is ICUI stock a buy or sell?

A: The dominant strategy among neural network is to Buy ICUI Stock.

Q: Is ICU Medical Inc. Common Stock stock a good investment?

A: The consensus rating for ICU Medical Inc. Common Stock is Buy and assigned short-term B3 & long-term B3 forecasted stock rating.

Q: What is the consensus rating of ICUI stock?

A: The consensus rating for ICUI is Buy.

Q: What is the prediction period for ICUI stock?

A: The prediction period for ICUI is (n+16 weeks)